Table 1.
Personal and professional characteristics of 106 responding oncologists.
Fig 1.
Discussions of costs in clinical practice.
A: Reported frequency of discussions about costs in the past 12 months by oncologists. B: Clinic personnel reported as being responsible for discussion of costs.
Fig 2.
Reported frequency of discussions in the last 12 months about specified out-of-pocket costs.
PBS–Pharmaceutical Benefits Scheme (medicines subsidised by the government). Non-PBS–Not on the Pharmaceutical Benefits Scheme (medicines not subsidised by the government).
Fig 3.
Characteristics associated with reported frequency of discussions of out-of-pocket costs with patients.
*FRACP = Fellow of Royal Australasian College of Physicians.
Fig 4.
Strategies to facilitate discussion of out-of-pocket (OOP) costs in the clinic.
*IFC = Standard for Informed Financial Consent.
Fig 5.
Current and potential barriers to discussion of costs in clinics by oncologists.
Fig 6.
Oncologists’ familiarity with aspects of financial burden.
Fig 7.
Oncologists’ views on tools to assist in management of financial burden in the clinic.